Status:
TERMINATED
Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Frontotemporal Dementia
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18-90 years
Brief Summary
Amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD) is a rare clinical entity, in which both disorders are variably associated in the same patient or within the family. This adult-o...
Detailed Description
The objective of this study without direct individual benefit is to confirm the linkage with one or another region of the two identified regions (chromosomes 9 and 15) or to identify a new implicated ...
Eligibility Criteria
Inclusion
- ALS with FTD, "pure" FTD but with knowledge of relatives with ALS-FTD or "pure" ALS, "pure" ALS but with knowledge of relatives with ALS-FTD or "pure" FTD (not carriers of a mutation in the tau and SOD1 genes), relatives signing the informed consent
Exclusion
- Minors, persons refusing to sign the informed consent
Key Trial Info
Start Date :
September 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00159198
Start Date
September 1 2002
End Date
June 1 2007
Last Update
September 8 2008
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de la Côte de Nacre
Caen, France, 14000
2
Centre Hospitalier Universitaire de Lille
Lille, France, 59000
3
Hôpital La Timone
Marseille, France, 13005
4
Hôpital Sainte-Marguerite
Marseille, France, 13009